☰

Rebecca Stadel, Ph.D. - Publications

Affiliations: 
2008 Albany Medical College of Union University 
Area:
Pain research
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Stadel R, Ahn KH, Kendall DA. The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. Journal of Neurochemistry. 117: 1-18. PMID 21244428 DOI: 10.1111/J.1471-4159.2011.07186.X  0.37
2010 Stadel R, Carpenter AB, Nalwalk JW, de Esch IJ, Janssen E, Hough LB. Inhibition of brain [(3)H]cimetidine binding by improgan-like antinociceptive drugs. European Journal of Pharmacology. 632: 33-8. PMID 20138862 DOI: 10.1016/J.Ejphar.2010.01.026  0.668
2008 Stadel R, Yang J, Nalwalk JW, Phillips JG, Hough LB. High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 614-21. PMID 18094038 DOI: 10.1124/Dmd.107.017889  0.583
2007 Hough LB, Nalwalk JW, Phillips JG, Kern B, Shan Z, Wentland MP, de Esch IJ, Janssen E, Barr T, Stadel R. CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist. Neuropharmacology. 52: 1244-55. PMID 17336343 DOI: 10.1016/J.Neuropharm.2007.01.004  0.694
2003 Cannon KE, Nalwalk JW, Stadel R, Ge P, Lawson D, Silos-Santiago I, Hough LB. Activation of spinal histamine H3 receptors inhibits mechanical nociception. European Journal of Pharmacology. 470: 139-47. PMID 12798951 DOI: 10.1016/S0014-2999(03)01737-0  0.457
2002 Hough LB, Nalwalk JW, Stadel R, Timmerman H, Leurs R, Paria BC, Wang X, Dey SK. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors. The Journal of Pharmacology and Experimental Therapeutics. 303: 314-22. PMID 12235266 DOI: 10.1124/Jpet.102.036251  0.68
Show low-probability matches.